Implantable Drug Delivery Devices: Worldwide Markets to 2023 - Key Growth Opportunities and Leading Player Profiles - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 27, 2018--The “Global Implantable Drug Delivery Devices Market - Segmented by Product Type, Technology, Application, Geography - Growth, Trends, and Forecasts (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.
The implantable drug delivery devices market is expected to grow at a CAGR of 7.8%.
The increase in burden of chronic diseases is affecting the large patient population which increases the number of surgeries and hence drives the implantable drug delivery devices market. The other driving factors include increasing demand for minimally invasive procedures and emergence of novel products.
Due to the substantial amount of high cost of devices and surgery costs, the adoption rate is less which is restraining the growth of implantable drug delivery devices market. The other restraining factors also includes stringent regulatory scenario.
North America is expected to dominate the implantable drug delivery devices market owing to new product launches in this region. Asia Pacific region is also anticipated to grow, attributed to the steadily growing healthcare spending as well as awareness levels of implantable drug delivery devices. The regulatory policies and healthcare infrastructure quality are further anticipated to broaden the scope for growth in this region.
Key Developments in the MarketMedtronic Plc has received FDA approval of a new clinician programmer for use with the SynchroMed(TM) II Intrathecal Drug Delivery system, an implantable pump that provides targeted drug delivery for chronic pain and severe spasticity. Teleflex signs a new agreement with Premier for implantable infusion ports. The agreement begins November 1, 2016, and extends through October 31, 2019.
Companies ProfiledAbbott Allergan Boston Scientific Corporation Bausch and Lomb Inc. Delpor Inc. Medtronic Novartis (Alcon) pSivida Corp. Teleflex Incorporated 3M’s Health Care
Key Topics Covered
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Implantable Drug Delivery Devices Market Overview
6. Implantable Drug Delivery Devices Market Dynamics
7. Implantable Drug Delivery Devices Market Segmentation
8. Company Profiles & Competitive Landscape
9. Future of the Implantable Drug Delivery Devices Market
For more information about this report visit https://www.researchandmarkets.com/research/lgxpnj/implantable_drug?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180927005533/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Drug Delivery
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/27/2018 09:43 AM/DISC: 09/27/2018 09:43 AM